Raptiva and Pharyngolaryngeal pain - a phase IV clinical study of FDA data

Summary:

Pharyngolaryngeal pain is reported as a side effect among people who take Raptiva (efalizumab), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Aspirin,.

The phase IV clinical study analyzes which people have Pharyngolaryngeal pain when taking Raptiva. It is created by eHealthMe based on reports of 3,760 people who have side effects when taking Raptiva from the FDA, and is updated regularly.

What is Raptiva?

Raptiva has active ingredients of efalizumab. It is often used in psoriasis. eHealthMe is studying from 3,769 Raptiva users. Check the latest studies of Raptiva.

What is Pharyngolaryngeal pain?

Pharyngolaryngeal pain is found to be associated with 589 drugs and 809 conditions by eHealthMe. Check the latest studies of Pharyngolaryngeal pain.

On Jul, 19, 2026

3,760 people reported to have side effects when taking Raptiva.
Among them, 12 people (0.32%) have Pharyngolaryngeal pain.

Could Raptiva cause Pharyngolaryngeal pain?

Among these 12 people:

How long have people been on Raptiva when they have Pharyngolaryngeal pain? *

What is the gender of people who have Pharyngolaryngeal pain when taking Raptiva? *

female: 75 %
male: 25 %

What is the age of people who have Pharyngolaryngeal pain when taking Raptiva? *

What are other drugs people take besides Raptiva? *

What are other side effects people have besides Pharyngolaryngeal pain? *

Fever: 4 people, 33.33%
Headache (pain in head): 4 people, 33.33%
Autoimmune Disorder (a condition in which the immune system attacks the body's normal substances and tissue): 3 people, 25.00%
Cough: 3 people, 25.00%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 2 people, 16.67%
Renal Impairment (severely reduced kidney function): 2 people, 16.67%
Cardiac Failure Congestive: 2 people, 16.67%
Lymphocytosis (an increase in the number or proportion of lymphocytes in the blood): 2 people, 16.67%
Coombs Test Positive: 2 people, 16.67%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Raptiva and have Pharyngolaryngeal pain?

- Check whether Pharyngolaryngeal pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Raptiva:

Raptiva (3,769 reports)

Browse all side effects of Raptiva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pharyngolaryngeal pain:

Pharyngolaryngeal pain (589 drugs)

Browse all the conditions that are associated with Pharyngolaryngeal pain:

Pharyngolaryngeal pain (809 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on efalizumab (the active ingredients of Raptiva) and Raptiva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.